Life Expectancy During the Covid-19 Pandemic: A Semi-Parametric Difference-in-Differences Analysis by Polemis, Michael & Stengos, Thanasis
Munich Personal RePEc Archive
Life Expectancy During the Covid-19
Pandemic: A Semi-Parametric
Difference-in-Differences Analysis
Polemis, Michael and Stengos, Thanasis
University of Piraeus, University of Guelph
22 September 2020
Online at https://mpra.ub.uni-muenchen.de/103051/
MPRA Paper No. 103051, posted 28 Sep 2020 13:33 UTC
1 
 
Life Expectancy During the Covid-19 Pandemic:  
A Semi-Parametric Difference-in-Differences Analysis   
 
Michael L. Polemisa,b*, Thanasis Stengosc 
a University of Piraeus, Department of Economics, Piraeus, Greece (corresponding author) 
b Hellenic Competition Commission, Athens, Greece. 
c University of Guelph, Department of Economics, Ontario, Canada  
 
September 2020  
 
Abstract  
The scope of this note is to investigate the causal effects of the COVID-19 pandemic on life 
expectancy over a sample of 47 countries split into two groups. The first one includes countries 
that have adopted general lockdown measures (treatment group), while the second one consists of 
countries that have imposed social distancing measures other than a national lockdown (control 
group). The investigated period starts from the first confirmed European case back (25.01.2020) 
until 28.07.2020 and covers the first wave of the pandemic for the sample countries. The empirical 
results based on a Semi-Parametric Difference-in-Differences framework, suggest a decline in life 
expectancy at birth estimated to 1.38 years on average even though the countries who did 
implement the lockdown measures were motivated and willing to do so. However, the decrease in 
life expectancy would have been double (2.9 years) in the absence of such willingness to adopt the 
policy. Lastly, the findings support the argument that national lockdown would be an effective 
policy tool to the hands of regulators and health practitioners to mitigate the negative effects of the 
pandemic infection it is pursued by motivated and willing participant countries.   
 
 
Keywords: Covid-19; Life expectancy; Lockdown; Social distancing; Semi-parametric 
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1. Introduction  
 
The COVID-19 pandemic has severely stressed health systems all over the world in an 
unforeseen way, potentially leading to increases in morbidity and mortality rate (see for example 
Connor, et al, 2020; Vandoros 2020; Trias-Llimós and Bilal 2020). These increases, however, 
seem to negatively affect life expectancy triggering significant consequences in all the aspects of 
social life (Marois et al, 2020). To give but an example of the rapid penetration of the pandemic 
to humanity, it is estimated that over 30,5 million Covid-19 cases have been reported globally, 
leading to nearly 952,000 deaths as of 19 September 2020 (Johns Hopkins University, 2020).  
It is noteworthy that the impact of this unprecedented situation on public health would have 
been even worse by the absence of restrictive measures to curb the spread of the pandemic (e.g. 
lockdowns, physical distancing, compulsory masking, flights cancellation, etc). This paper 
contributes to the existing literature since it is the first study so far that examines the impact of the 
national lockdown adopted by 33 countries on life expectancy at birth. In other words, this study 
investigates the links of life expectancy, which is a long-term issue with the effect of a short-run 
policy of a national lockdown.  
For this reason, the flexible Semiparametric Difference-in-Differences (SDID) approach 
developed in Abadie (2005) is employed to estimate how the effect of treatment (national 
lockdown) varies with changes in individual characteristics. The reason for using this method over 
the traditional linear DID estimator is that the former is mostly suited for longitudinal surveys with 
a baseline and follow-up rounds (e.g. lockdown periods) as in this case (see Houngbedji, 2016 and 
Abadie 2005).   
Despite the profound interest of the scientific community in studying the consequences of 
COVID-19 on public health (see among others Connor et al, 2020; Elgar et al, 2020; Vandoros, 
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2020; Nivette et al, 2020; Preis et al, 2020), little attention has been paid on the casual effects of 
the restrictive measures adopted to mitigate the spread of the pandemic infection on life expectancy 
at birth.  
The most related work to ours is the recent study of Llimós and Bilal (2020), where they 
examine the impact of COVID-19 on the annual life expectancy in the region of Madrid. This 
study estimates the expected changes in annual life expectancy accounting for the excess mortality 
over the period from 9.3.2020 to 10.05.2020. The empirical findings support a decline in life 
expectancy at birth of 1.9 and 1.6 years for men and women, respectively. The authors argue that 
the relevant figures could be even bigger since their estimates are based on the existing mortality 
pattern. Moreover, they argue that a decline mortality rate is also possible due to the existence of 
a “harvesting” effect, as happened in other flu pandemics.  
In a subsequent study, Marois et al (2020) provide first estimates of the potential direct 
impact of the COVID-19 pandemic on life expectancy for several countries and regions (North 
America and Europe, Latin America, and the Caribbean, Southeastern Asia, and Sub-Saharan 
Africa). They employ a microsimulation model based on several assumptions (e.g. mortality rate, 
prevalence rate, fertility, etc) that calibrates the life histories of 100,000 individuals by five-year 
age groups over a period of 52 weeks (one year). The empirical findings support that in all 
prevalence scenarios, life expectancy would drop even by 9 years (North America and Europe). 
However, life expectancy will not be substantially affected when the prevalence COVID-19 rate 
does not exceed 2%.    
2.  Data and Methodology  
 
The sample consists of an unbalanced panel data set comprising of 47 countries, over the 
period 25.01.2020 to 28.07.2020 (T = 186). All the variables were obtained from Roser et al (2020) 
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and extracted on 30 July 2020.1 We must mention though that values included in this dataset may 
be changed in later releases, as is sometimes the case. The starting date for the national lockdown 
measure adopted by each sample country is shown in Table 1. As it is evident, the majority of the 
(treatment) countries implemented this restrictive measure shortly after the declaration of the 
pandemic by the World Health Organization (11.03.2020).2  
<Table 1 about here> 
Table 2 presents the summary statistics for the sample variables used in this study. It 
appears that the diabetes prevalence exhibits the lowest standard deviation among the sample 
variables equal to 1.997, while the GDP per capita the highest. The relevant variable is positively 
skewed (0.863) and the (excess) kurtosis value suggests a platykurtic distribution (>3). On the 
contrary, the dependent variable (life expectancy) is negatively skewed (-1.209) and does not 
follow the normal distribution, which is also the case for all the rest variables. It is noteworthy that 
the rest variables are positively skewed (heavy-tailed) revealing a leptokurtic distribution.  
<Table 2 about here> 
One of the assumptions in the interpretation of using difference-in-differences estimators 
to measure the effect of policy intervention as a causal effect is that, in the absence of the treatment, 
the outcome variable follows the same trend in treated and untreated groups (Vandoros, 2020; 
Card and Kruger, 1994). This assumption may not be credible if selection for treatment is 
correlated with characteristics that affect the dynamic of the outcome variable (Imbens and 
Wooldridge, 2009; Hirano et al, 2003).   
 
1 Retrieved from: https://ourworldindata.org/coronavirus. 
2 However, Slovakia is the only country that adopted national lockdown measures nearly one month after the 
declaration of the pandemic (08.04.2020).  
5 
 
Abadie (2005) introduces the SDID estimator addressing the imbalance of characteristics 
between treated and untreated groups through a reweighting scheme that allows differences in 
observed characteristics to create nonparallel outcome dynamics for the treated and untreated 
groups. Since the characteristics are treated nonparametrically any estimation error caused by 
functional misspecification is avoided (Chang, 2018). Furthermore, the SDID estimator allows for 
the use of covariates to describe how the average effect of the treatment varies for different groups 
of the treated population. The estimator is based on reweighing the trend for the untreated 
participants using a semiparametric estimator of their propensity score using a polynomial series 
of the covariates (Abadie 2005).  
Following the SDID methodology, the effect of national lockdown can be disentangled by 
identifying two groups. The first group includes 34 countries (treatment group), that pursued the 
measure of the national lockdown. The second group (control group), comprises of the rest 13 
countries (Belarus, Estonia, Iceland, Malta, Sweden, Switzerland, Japan, Malawi, Nicaragua, 
South Korea, Taiwan, Timor, and Uruguay) that did not impose a general (national) lockdown but 
only transitory protective measures (e.g. school closures, social distancing, COVID testing, health 
checks, etc).3  
3.  Results and discussion  
 
We begin our analysis by estimating with OLS the following linear benchmark model      𝐿𝑖𝑓𝑒 𝑒𝑥𝑝𝑒𝑐𝑡𝑎𝑛𝑐𝑦it =  bo + b1Treatedi + b2GDPit + b2Populationit + b3Median ageit +  
b4Male smokersit+ b5Female smokersit + b6Female smokers+b7Poverty + b8Hospital +  
b9Diabetes + εit                     (1) 
 
3 For the empirical application of the SDID estimator, we used the “absdid” command in Stata, developed in 
Houngbedji (2016). The relevant command estimates the average treatment of the treated (ATT) by comparing change 
over time of the outcome of interest across treatment groups while adjusting for differences between treatment groups 
on the observable characteristics at baseline that are correlated to the propensity score (Houngbedji, 2016).  
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The dependent variable in Eq. 1 is the life expectancy at birth in country i at day t and 
remains constant throughout the sample period. Treatedi is a dummy variable equal to one for the 
countries adopted the national lockdown and zero otherwise. In other words, the policy 
intervention is simply a dummy variable in this benchmark linear OLS model without any 
Difference-in-Difference correction. GDP denotes the per capita gross domestic product at 
purchasing power parity in constant 2011 USD dollars. Population denotes the number of people 
divided by land area (density), measured in square kilometers. Median age denotes the median age 
of the population. Male and female smokers denote the share of males and females who smoke. 
Poverty denotes the share of the population living in extreme poverty. Hospital denotes the hospital 
beds available per 1,000 people and can be used as a proxy of the health infrastructure. Diabetes 
denotes diabetes prevalence as a percentage of the population aged 20 to 79 in 2017. Finally, εit is 
the error term.  
<Table 3 about here> 
The empirical findings of the benchmark model are presented in Table 3. As it is evident, 
the COVID-19 pandemic reduces life expectancy by about 2.9 years (95% CI from -3.107 to -
2.776) since the relevant dummy variable (Treated) is negative and statistically significant. This 
means that the absence of willingness and motivation to implement the policy intervention measure 
of the national lockdown (counterfactual), the pandemic infection would have an inversely related 
effect on life expectancy. Most of the variables have the anticipated signs and are statistically 
significant at a 1% level of significance.   
Having estimated the benchmark model, the analysis focuses on the interpretation of the 
empirical findings of the SDID estimator. Table 4 presents the empirical results of the SDID 
econometric analysis. Specifically, Model (1) reports estimates of the average life expectancy at 
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birth. Model (2) shows how the life expectancy varies with economic (GDP per capita, extreme 
poverty), demographic (e.g. population, hospital beds), and medical characteristics (e.g. male and 
female smokers, diabetes prevalence). The coefficients reported in (1) and (2) are estimated using 
a logit specification of degree 4 to estimate the propensity score (SLE).4  
<Table 4 about here> 
As it is evident, from the relevant table, life expectancy is estimated to be decreased by 
1.38 years on average in all the models. A careful inspection of the relevant table reveals some 
important findings. First, if we isolate all the additional covariates affecting life expectancy at birth 
(e.g. income effect, health conditions, population density, etc), we notice that there is a decrease 
in the post-treatment period compared to the control group (see column 1). The relevant SDID 
coefficient is negative (-1.158) and statistically significant, while the 95% confidence interval 
ranges from -1.588 to -0.727 during the first wave of the pandemic. This finding indicates that the 
policy intervention change (national lockdown) adopted by the 33 sample countries reduces annual 
life expectancy at birth by 1.9 years since these countries were willing, motivated by health safety 
considerations and ready to do so. The relevant estimate is in alignment with the study of Llimós 
and Bilal (2020).  
  Second, similar findings are reported when several independent variables enter the model 
(see column 2). In this case, the SDID estimator remains negative and statistically significant, 
though its magnitude is slightly larger than the previous estimate (1.606 compared to 1.158). 
Specifically, annual life expectancy at birth will be reduced by 1.606 years,  95% CI (-2.78, 5.99), 
while the rest of the variables have a positive and statistically significant correlation with life 
 
4 We have also used a linear polynomial function (LPM) of degree 4 to approximate the propensity score and the 
results were quite similar. To preserve space, the empirical findings are available from the authors on request.   
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expectancy as it is documented by previous studies (see among others Miladinov, 2020; Shafi and 
Fatima, 2019). 
All in all, this study argues that the national lockdown measure coincides with reductions 
in life expectancy. However, the magnitude of the reduction rate would have been larger in the 
case of an absence of willingness, motivation and readiness of the participant countries to 
implement this intervention. In that case, the estimated reduction in life expectancy would have 
been by almost three years from the current 2019 level. The relevant finding justifies the 
effectiveness of the national lockdown as a restrictive policy tool to combat the novel coronavirus 
disease. Combining the two important findings, this study supports the notion that short-run health 
policies (e.g. national lockdown) incur long term implications (e.g. reduction in life expectancy 
growth). A similar result is also documented in the study of Verstraeten, et al (2016), where it is 
argued that a short-run policy change (decolonization) incurs negative effects at life expectancy 
growth in the Caribbean states. A subsequent study by Montez et al, (2020) for the US seems also 
to support this claim.5 In this case, the link between life expectancy which constitutes a long-term 
issue with the short-run policy of a national lockdown can be explained through the channel that 
people's health may be compromised at birth. This could be partly justified by the fact that health 
resources have moved to take care of the reported COVID-19 infection cases, or early premature 
births.   
 
 
 
 
5 This study supports that shifts in state policy measures (e.g. liberal or conservative) predict life expectancy and US 
longevity. 
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4.  Conclusions  
This study employs a flexible SDID approach, to investigate the effect of a short-run health 
policy (e.g. national lockdown) on a long-run health issue (life expectancy). The econometric 
analysis suggests a structural link between the adoption of lockdown measures by the national 
governments to face the pandemic crisis and life expectancy at birth. The results indicate that the 
most stringent policy intervention such as a national lockdown incurs a decrease in life expectancy 
by 1.38 years on average. The negative relationship remains robust under several SDID 
specifications. In the absence of a willingness to adopt such a policy by the countries involved 
would have resulted in life expectancy at birth to be reduced by a larger amount equal to 2.9 years 
(e.g. more than the double). Lastly, this study has significant implications for policymakers and 
health practitioners, since a decrease in life expectancy due to the pandemic could imply a higher 
death toll as a result of the imminent second wave of the pandemic, pushing the national healthcare 
systems to their limits. Therefore, future research may shed light on this issue by extending the 
sample and including more covariates (spatial characteristics, demographic conditions, education 
level, etc).  
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Table 1: National lockdown coverage: Dates and Countries  
Date AL  AT BE BG HR CY CZ DK  FI FR DE GR HU IR IT LV LI  LT LU MD MC ME 
09.03.2020                       
10.03.2020                       
11.03.2020 
Pandemic 
                      
12.03.2020                       
13.03.2020                       
14.03.2020                       
15.03.2020                       
16.03.2020                    `   
17.03.2020                       
18.03.2020                       
19.03.2020                       
20.03.2020                       
21.03.2020                       
22.03.2020                       
23.03.2020                       
24.03.2020                       
25.03.2020                       
26.03.2020                       
27.03.2020                       
28.03.2020                       
29.03.2020                       
30.03.2020                       
31.03.2020                       
Date NL MK NO PL PT RO RS SK SI ES UA UK           
09.03.2020                       
10.03.2020                       
11.03.2020 
Pandemic 
                      
12.03.2020                       
13.03.2020                       
14.03.2020                       
15.03.2020                       
16.03.2020                       
17.03.2020                       
18.03.2020                       
19.03.2020                       
20.03.2020                       
21.03.2020                       
22.03.2020                       
23.03.2020                       
24.03.2020                       
25.03.2020                       
26.03.2020                       
27.03.2020                       
28.03.2020                       
29.03.2020                       
30.03.2020                       
31.03.2020                       
01.04.2020                       
02.04.2020                       
03.04.2020                       
04.04.2020                       
05.04.2020                       
06.04.2020                       
07.04.2020                       
08.04.2020                       
09.04.2020                       
Notes: Light shaded areas denote the pre-lockdown period, while dark shaded areas represent the lockdown period. AL = Albania, AT = Austria, BE = Belgium, BG = 
Bulgaria, HR = Croatia, CY = Cyprus, CZ = Czech Republic, DK = Denmark, FI = Finland, FR = France, DE = Germany, GR = Greece, HU = Hungary, IR = Ireland, 
IT = Italy, LV = Latvia, LI = Liechtenstein, LT = Lithuania, LU = Luxembourg, MD = Moldova,  MC = Monaco, ME = Montenegro, NL = Netherlands, MK = Northern 
Macedonia, NO = Norway, PL = Poland, PT = Portugal, RO = Romania, RS = Serbia, SK = Slovakia, SI = Slovenia, ES = Spain, UA = Ukraine, UK = United Kingdom. 
Source: Authors’ elaboration from Wikipedia and various national websites.     
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Table 2: Summary statistics  
         
Variable Observations Mean Median  Min Max Standard 
deviation  
Skewness Kurtosis 
         
GDP 7,372 33,504 32,606 1,095 94,278 17,875 0.863 4.672 
Population 7,686 602.5 106.7 3.404 19,348 2,862 6.356 41.65 
Median age  7,558 41.21 42.30 18 48.20 5.415 -2.701 11.90 
Male smokers  7,063 34.52 33.10 15.20 78.10 11.39 0.987 5.107 
Female smokers  7,063 21.57 21.30 4.400 44 8.423 0.034 3.056 
Poverty 5,300 3.259 0.500 0.100 71.40 11.27 5.206 30.33 
Hospital  7,686 5.355 4.530 0.900 13.80 2.918 1.255 4.262 
Diabetes  7,686 6.414 5.760 3.280 11.47 1.997 0.701 2.581 
Life expectancy  7,872 79.68 81.32 64.26 86.75 4.047 -1.209 4.887 
         
Notes: GDP denotes the per capita gross domestic product at purchasing power parity in constant 2011 USD dollars, 
Population denotes the number of people divided by land area (density), measured in square kilometers, Median age 
denotes the median age of the population, Male smokers denotes the share of males who smoke, Female smokers 
represents the percentage of female smokers, Poverty denotes the share of the population living in extreme poverty, 
Hospital, denotes the hospital beds available per 1,000 people, Diabetes, denotes the diabetes prevalence as a 
percentage of the population aged 20 to 79 in 2017 and finally Life expectancy denotes the life expectancy at birth in 
2019.  
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Table 3: Linear regression results (benchmark model)       
  
Dependent variable: 
Life expectancy  
 OLS 
Treated   -2.942*** 
(0.0845) 
GDP   0.000131*** 
(2.62e-06) 
Population   0.000841*** 
(0.000109) 
Median age  0.460*** 
(0.00892) 
Male smokers  0.0442*** 
(0.00368) 
Female smokers  -0.0298*** 
(0.00286) 
Poverty  -0.0468*** 
(0.00315) 
Hospital   -0.557*** 
(0.0163) 
Diabetes  0.250*** 
(0.0139) 
Constant 
 
Observations 
R-squared  
 58.41*** 
(0.438) 
4,991 
0.835 
Notes: Treated is a dummy variable taking value one for countries that imposed national lockdown and zero otherwise, 
GDP denotes the per capita gross domestic product at purchasing power parity in constant 2011 USD dollars, 
Population denotes the number of people divided by land area (density), measured in square kilometers, Median age 
denotes the median age of the population, Male smokers denotes the share of males who smoke, Female smokers 
represents the percentage of female smokers, Poverty denotes the share of the population living in extreme poverty, 
Hospital, denotes the hospital beds available per 1,000 people, Diabetes, denotes the diabetes prevalence as a 
percentage of the population aged 20 to 79 in 2017, Life expectancy denotes the life expectancy at birth in 2019. 
Robust standard errors in parentheses. Significant at *** p<0.01.   
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Table 4: SDID regression results (control & treatment sample)     
 SLE 
Dependent variable: 
Life expectancy  
(1) (2) 
SDID estimator 
Constant  -1.158*** 
[-1.588 to 0.727] 
-1.606*** 
[-2.78 to 5.99] 
Covariates    
GDP  - 0.0000485** 
[9.74e-06 to 0.00008] 
Population  - 0.0117*** 
[0.008 to 0.014] 
Male smokers - -0.103 
[-0.250 to 0.043] 
Female smokers - -0.360*** 
[-0.472 to -0.247] 
Poverty - -0.492*** 
[-0.756 to -0.227] 
Hospital  - -0.296 
[-0.795 to 0.204] 
Diabetes - -1.134*** 
[-1.684 to -0.584] 
Observations 4,991 4,991 
Notes: GDP denotes the per capita gross domestic product at purchasing power parity in constant 2011 USD dollars, 
Population denotes the number of people divided by land area (density), measured in square kilometers, Male smokers 
denotes the share of males who smoke, Female smokers represents the percentage of female smokers, Poverty denotes 
the share of the population living in extreme poverty, Hospital, denotes the hospital beds available per 1,000 people, 
Diabetes, denotes the diabetes prevalence as a percentage of the population aged 20 to 79 in 2017, Life expectancy 
denotes the life expectancy at birth in 2019. Time and country dummies are included but not reported. Robust 
confidence interval in brackets. Significant at *** p<0.01.   
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